Fumaric Acid

Fumaric Acid

SCHEMBL9549941

CN1CCC2CC1N(C)c1ccc(O)cc12.COC(N)=O.O=C(O)/C=C/C(=O)O

nearest known ligand 0.42

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADRB1ADRB2ATP4AATP4BAXLCHRM2CHRM3DRD2FLT3HRH1HTR2AHTR2BHTR2CKCNH2KMT2AMAP2K1MAP2K2MEN1MLNRPLK4RENS1PR1SLC6A2SLC6A4atpAatpBatpCatpDatpEatpFatpFHatpGpol

The experimentally established mechanism targets of Fumaric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.42
BLM P54132 2/20 0.42
NPSR1 Q6W5P4 2/20 0.42
G6PD P11413 1/20 0.42
KDM4E B2RXH2 1/20 0.42
GMNN O75496 1/20 0.42
ALDH1A1 P00352 1/20 0.42
LMNA P02545 1/20 0.42
THRB P10828 1/20 0.42
PMP22 Q01453 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
ACHE P22303 2/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Fumaric Acid SCHEMBL9549960 1.00 MAPT (0.42) MAPTBLMNPSR1G6PDKDM4E
Fumaric Acid SCHEMBL9549906 0.93 MAPT (0.47) MAPTBLMNPSR1G6PDKDM4E
Fumaric Acid SCHEMBL9549924 0.93 MAPT (0.47) MAPTBLMNPSR1G6PDKDM4E
Acetic Acid SCHEMBL9549932 0.85 MAPT (0.37) MAPTBLMNPSR1G6PDKDM4E
SCHEMBL9549900 0.83 KDM4E (0.39) MAPTKDM4EACHE
SCHEMBL9550005 0.71 FDFT1 (0.37) LMNA
SCHEMBL9549940 0.71 ACHE (0.42) BLMKDM4EALDH1A1LMNASMN1; SMN2
Fumaric Acid SCHEMBL9549925 0.68 MEN1 (0.41) MAPTALDH1A1
SCHEMBL9549928 0.68 CYP2D6 (0.37) LMNA
SCHEMBL9550053 0.68 ACHE (0.33) MAPTALDH1A1LMNAACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5264575-A Reacting 1,3-benzodiazocine-8-ol derivative with lutidine/2,6-/, triisoproylsilyltrifluoro methane, formed intermediate reacted with lithium chloride, tetrabutylammonium fluoride and isocyanate HOECHST-ROUSSEL PHARMACEUTICALS INC. (US) 1993-11-23 US disclosed
US-5097033-A Aminoethyl quinoline 2-ones, intermediates for analgesic, and cholinergic agents for memory disorders HOECHST-ROUSSEL PHARMACEUTICALS INC. (US) 1992-03-17 US disclosed
US-5010083-A Cognition activator; Alzheimer*s disease HOECHST-ROUSSEL PHARMACEUTICALS, INC. (US) 1991-04-23 US disclosed